IRMD News and Press, iRadimed Corporation From 11/03/23

2023-11-03 08:16:46 ET More on iRadimed IRadimed Continues Ploughing Along With Superb Economic Characteristics Seeking Alpha’s Quant Rating on iRadimed Historical earnings data for iRadimed Financial information for iRadimed For further detail...

Reports record revenue of $16.5 million for the third quarter of 2023. GAAP diluted EPS of $0.40 and non-GAAP diluted EPS of $0.43. Third quarter operating income of $5.9 million, an increase of 43% compared to the same period in 2022. WINTER SPRINGS, Fla., Nov. 03, 2023 (...

HST Global Inc (HSTC) is expected to report for quarter end 2023-09-30 Air China Ltd ADR - Level I (AIRYY) is expected to report for Q3 2023 GrafTech International Ltd. (EAF) is expected to report $-0.05 for Q3 2023 Cardinal Health Inc. (CAH) is expected to report $1.4 for Q1 2024 ...

iRadimed Corporation (IRMD) is expected to report $0.34 for Q3 2023

WINTER SPRINGS, Fla., Oct. 26, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 third quarter financial results before the market opens on Friday, November 3 rd . IRADIMED management will host a conference call the same d...

WINTER SPRINGS, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that the Company will be participating in two upcoming investor conferences. Iradimed management is scheduled to participate in investor meetings at the...

2023-08-03 08:27:12 ET iRadimed press release ( NASDAQ: IRMD ): Q2 Non-GAAP EPS of $0.36 beats by $0.06 . Revenue of $16.13M (+26.8% Y/Y) beats by $0.47M . For the third quarter of 2023, the Company expects to report revenue of $16.1 million to $16.3 million, G...

Reports record revenue of $16.1 million for the second quarter of 2023 GAAP diluted EPS of $0.33 and non-GAAP diluted EPS of $0.36 Operating income was $5.0 million and increased by 19% Announces third quarter and full year 2023 financial guidance WINTER SPRINGS, F...

WINTER SPRINGS, Fla., July 27, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 second quarter financial results before the market opens on Thursday, August 3 rd . Iradimed management will host a conference call the same ...

2023-06-09 13:28:06 ET Summary IRadimed Corporation's Q1 FY'23 results show a 26% YoY growth in revenues, driven by strong domestic and international sales. The company's economic earnings and incremental returns on capital indicate a strong growth strategy and potential for scala...